Citius Pharmaceuticals, Inc. (CTXR) Revenue 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$90,000FY2022 · since FY2017: $50,000 → $90,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $90,000 | +0.0% |
| FY2021 | $90,000 | +0.0% |
| FY2020 | $90,000 | +0.0% |
| FY2019 | $90,000 | +20.0% |
| FY2018 | $75,000 | +50.0% |
| FY2017 | $50,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice